Evidence map›Paper›PMID 35209167›Full record

ReviewMolecules (Basel, Switzerland)2022

An Update of the Sanguinarine and Benzophenanthridine Alkaloids' Biosynthesis and Their Applications.

José Ignacio Laines-Hidalgo, José Armando Muñoz-Sánchez, Lloyd Loza-Müller, Felipe Vázquez-Flota

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Whole transcriptome sequencing fromFrontiers in plant science · 2026
    Article
  5. Review
  6. Sanguinarine-Chelerythrine fromPharmaceutics · 2025
    Article
  7. Article
  8. Article
  9. Recent Advances in Alkaloids fromMolecules (Basel, Switzerland) · 2024
    Review
  10. Review
  11. The induced and intrinsic resistance ofMicrobiology spectrum · 2024
    Article
  12. Article
  13. Article
  14. Alkaloids inFrontiers in pharmacology · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Mitogen-Activated Protein Kinase Phosphatases: No Longer Undruggable?Annual review of pharmacology and toxicology · 2023
    Review
  20. California poppy (Frontiers in plant science · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

José Ignacio Laines-HidalgoUnidad de Bioquímica y Biología Molecular de Plantas, Centro de Investigación Científica de Yucatán, Calle 43 No. 130, Chuburná, Merida 97205, Mexico.
José Armando Muñoz-SánchezUnidad de Bioquímica y Biología Molecular de Plantas, Centro de Investigación Científica de Yucatán, Calle 43 No. 130, Chuburná, Merida 97205, Mexico.
Lloyd Loza-MüllerUnidad de Bioquímica y Biología Molecular de Plantas, Centro de Investigación Científica de Yucatán, Calle 43 No. 130, Chuburná, Merida 97205, Mexico.
Felipe Vázquez-FlotaUnidad de Bioquímica y Biología Molecular de Plantas, Centro de Investigación Científica de Yucatán, Calle 43 No. 130, Chuburná, Merida 97205, Mexico.ORCID 0000-0002-3171-137X
Secretaría de Investigación, Innovación y Educación Superior · MX

Funding

Consejo Nacional de Ciencia y Tecnología CB-2016; 0285887
6 · The paper itself

Abstract

Benzophenanthridines belong to the benzylisoquinolic alkaloids, representing one of the main groups of this class. These alkaloids include over 120 different compounds, mostly in plants from the Fumariaceae, Papaveraceae, and Rutaceae families, which confer chemical protection against pathogens and herbivores. Industrial uses of BZD include the production of environmentally friendly agrochemicals and livestock food supplements. However, although mainly considered toxic compounds, plants bearing them have been used in traditional medicine and their medical applications as antimicrobials, antiprotozoals, and cytotoxic agents have been envisioned. The biosynthetic pathways for some BZD have been established in different species, allowing for the isolation of the genes and enzymes involved. This knowledge has resulted in a better understanding of the process controlling their synthesis and an opening of the gates towards their exploitation by applying modern biotechnological approaches, such as synthetic biology. This review presents the new advances on BDZ biosynthesis and physiological roles. Industrial applications, mainly with pharmacological approaches, are also revised.

Indexed as

AlkaloidsBenzophenanthridinesBiological ProductsBiosynthetic PathwaysDrug DevelopmentIsoquinolinesMedicine, TraditionalPlant Physiological PhenomenaStructure-Activity RelationshipAlkaloidsBenzophenanthridinesBiological ProductsIsoquinolinessanguinarinealkaloidsbenzophenanthridinesbenzylisoquinolinenatural productsspecialized metabolism

Identifiers

PMID35209167
PMCPMC8876366
OpenAlexW4214704709

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.